Form 4: Zomedica Corp. Director Rodney Williams Increases Stake with Recent Stock Purchase

Director Rodney James Williams purchased 100,000 shares of Zomedica Corp. at $0.069 per share, increasing his direct holdings.

Summary

• On March 17, 2025, Rodney James Williams, a director of Zomedica Corp., purchased 100,000 shares of the company's common stock at a price of $0.069 per share.
• This transaction increased Williams' direct holdings to 261,900 shares.
• Williams also indirectly owns 40,000 shares through Entrust Group f/b/o Rodney J. Williams IRA.
• A correction is being made to a previous filing (Form K filed on 3/18/2025) to include shares previously held and correct the total securities beneficially owned following the transaction.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. A director purchasing shares suggests confidence, but it's a relatively small transaction.

Positives

• A director's purchase of company stock can be seen as a positive signal, indicating confidence in the company's future prospects.

Industry Context

This filing is a routine disclosure related to insider trading activity. It provides transparency to the market regarding the transactions of company insiders.

Stakeholder Impact

• The stock purchase by a director could have a slightly positive impact on shareholder sentiment.

Key Dates

Keywords

Zomedica Corp, Rodney James Williams, stock purchase, director, beneficial ownership, Form 4, ZOM